Kyo026

PMCB

Short
Kyo026 Updated   
NASDAQ:PMCB   PharmaCyte Biotech, Inc
1Y
RSI is falling.
MFI is in a decline.

5Y
RSI is oversold.
MFI has topped and falling.

ALL
RSI is reaching oversold.
MFI is at a bottom.

Prediction: This has another drop and once the RSI has bottomed on some of the timeframes it should be ready to fill the gap up around $8.

For my educational purpose, not to be used as financial advice.
Comment: Position taken.
Comment: Sold 4% gain.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.